These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 1372502)

  • 1. Glycosulfatase activity of Helicobacter pylori toward gastric mucin.
    Slomiany BL; Murty VL; Piotrowski J; Liau YH; Sundaram P; Slomiany A
    Biochem Biophys Res Commun; 1992 Mar; 183(2):506-13. PubMed ID: 1372502
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glycosulfatase activity of H. pylori toward human gastric mucin: effect of sucralfate.
    Slomiany BL; Murty VL; Piotrowski J; Grabska M; Slomiany A
    Am J Gastroenterol; 1992 Sep; 87(9):1132-7. PubMed ID: 1381553
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of Helicobacter pylori glycosulfatase activity toward gastric sulfomucin by nitecapone.
    Murty VL; Piotrowski J; Morita M; Slomiany A; Slomiany BL
    Biochem Int; 1992 May; 26(6):1091-9. PubMed ID: 1632804
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glycosulfatase activity of Helicobacter pylori towards gastric sulfomucin: effect of nitecapone.
    Slomiany BL; Murty VL; Piotrowski J; Morita M; Slomiany A
    J Physiol Pharmacol; 1993 Mar; 44(1):7-16. PubMed ID: 8518427
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of Helicobacter pylori glycosulfatase activity towards human gastric sulfomucin by a gastroprotective agent, sulglycotide.
    Murty VL; Piotrowski J; Czajkowski A; Slomiany A; Slomiany BL
    Gen Pharmacol; 1993 Nov; 24(6):1463-6. PubMed ID: 8112521
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glycosulfatase activity of Porphyromonas gingivalis a bacterium associated with periodontal disease.
    Slomiany BL; Murty VL; Piotrowski J; Liau YH; Slomiany A
    Biochem Mol Biol Int; 1993 Apr; 29(5):973-80. PubMed ID: 8389637
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gastroprotective agents in mucosal defense against Helicobacter pylori.
    Slomiany BL; Murty VL; Piotrowski J; Slomiany A
    Gen Pharmacol; 1994 Sep; 25(5):833-41. PubMed ID: 7835626
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanism of Helicobacter pylori pathogenesis: focus on mucus.
    Slomiany BL; Slomiany A
    J Clin Gastroenterol; 1992; 14 Suppl 1():S114-21. PubMed ID: 1378466
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Helicobacter pylori moves through mucus by reducing mucin viscoelasticity.
    Celli JP; Turner BS; Afdhal NH; Keates S; Ghiran I; Kelly CP; Ewoldt RH; McKinley GH; So P; Erramilli S; Bansil R
    Proc Natl Acad Sci U S A; 2009 Aug; 106(34):14321-6. PubMed ID: 19706518
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of pH on Helicobacter pylori binding to human gastric mucins: identification of binding to non-MUC5AC mucins.
    Lindén S; Mahdavi J; Hedenbro J; Borén T; Carlstedt I
    Biochem J; 2004 Dec; 384(Pt 2):263-70. PubMed ID: 15260802
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assay of human gastric mucin as a natural antibiotic against Helicobacter pylori.
    Fukuda M; Kawakubo M; Ito Y; Kobayashi M; Lee H; Nakayama J
    Methods Enzymol; 2006; 415():164-79. PubMed ID: 17116474
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-Helicobacter pylori activities of ebrotidine. A review of biochemical and animal experimental studies and data.
    Slomiany BL; Piotrowski J; Slomiany A
    Arzneimittelforschung; 1997 Apr; 47(4A):475-82. PubMed ID: 9205747
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The role of gastric mucins in interactions with Helicobacter pylori].
    Radziejewska I
    Postepy Hig Med Dosw (Online); 2012 Jan; 66():60-6. PubMed ID: 22371407
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of gastric mucosal mucin receptor by Helicobacter pylori lipopolysaccharide.
    Piotrowski J; Slomiany A; Slomiany BL
    Biochem Mol Biol Int; 1993 Dec; 31(6):1051-8. PubMed ID: 7514919
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of Helicobacter pylori Infection on gastric mucin expression.
    Kang HM; Kim N; Park YS; Hwang JH; Kim JW; Jeong SH; Lee DH; Lee HS; Jung HC; Song IS
    J Clin Gastroenterol; 2008 Jan; 42(1):29-35. PubMed ID: 18097286
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel in vitro infection model of Helicobacter pylori using mucin-producing murine gastric surface mucous cells.
    Takahashi T; Matsumoto T; Nakamura M; Matsui H; Kiyohara H; Sasakawa C; Yamada H
    Helicobacter; 2004 Aug; 9(4):302-12. PubMed ID: 15270744
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Digestion of human gastric mucous by extracellular Helicobacter pylori enzyme].
    Tanaka N; Kuwayama H; Nakajima M
    Nihon Rinsho; 1993 Dec; 51(12):3163-5. PubMed ID: 7506799
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of cagA+ and cagA- strains of Helicobacter pylori on the human gastric mucus layer thickness.
    Al-Marhoon MS; Nunn S; Soames RW
    J Gastroenterol Hepatol; 2005 Aug; 20(8):1246-52. PubMed ID: 16048574
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Morphological aspects of the cytotoxic action of Helicobacter pylori.
    Taniguchi Y; Ido K; Kimura K; Satoh K; Yoshida Y; Takimoto T; Kihira K; Ookawara S; Mato M
    Eur J Gastroenterol Hepatol; 1994 Dec; 6 Suppl 1():S17-21. PubMed ID: 7537615
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of Helicobacter pylori colonization by sulfated gastric mucin.
    Piotrowski J; Slomiany A; Murty VL; Fekete Z; Slomiany BL
    Biochem Int; 1991 Jul; 24(4):749-56. PubMed ID: 1799374
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.